Table 3. Subsequent therapies of 177 RHCC patients according to AFP change.
Therapy | Group A (n= 51) | Group B (n= 43) | Group C(n=83) | P value |
---|---|---|---|---|
Any/none | 16/35 | 14/29 | 28/55 | 0.960 |
RFA Yes/no |
3/48 | 3/40 | 5/78 | 0.972 |
Resection Yes/no |
4/47 | 5/38 | 7/76 | 0.788 |
Liver transplantation Yes/no |
2/49 | 1/42 | 5/78 | 0.620 |
chemo-, radiotherapy Yes/no |
2/49 | 1/42 | 2/81 | 0.854 |
Sorafenib Yes/no |
5/46 | 4/39 | 9/74 | 0.959 |